Providing access to highly effective therapies in the communities where patients live is critical to improving outcomes. Safety of bsabs and CAR-T is continuously improving and we need partnerships to bring these therapies to more community oncology centers. #HemOnc #lymsm #MedSky

SCRI expert, Dr. Stephen Strickland presented interim results for SENTI-202 at #AACR2025. This CAR NK cell therapy shows potential in treating relapsed AML, with several patients achieving complete remission. Read more www.usnews.com/news/health-... #CancerResearch #CAR_NK_Therapy #AML #USNews

This is so incredibly sad for cancer and specifically cell and gene therapy. I am profoundly grateful to Peter for his service, collaboration and dedication through an incredibly impactful career. CAR-T therapies would not be where they are without his efforts. www.wsj.com/politics/top...

We owe him much for his leadership at CBER during a period of remarkable therapeutic advances. The havoc caused by this administration will have a devastating impact for years. www.washingtonpost.com/politics/202...

So many exciting developments in MCL in the past few years. Much more to come also with a lot of exciting clinical trials and investigational therapies being developed. #lymsm #HemeSky

Long awaited…Excited to see our multi-center effort of CD19 allo iPSC CAR-NK in B-cell #lymsm! Impt proof of concept: -very low CRS ✅ -no ICANS ✅ -multi dose off shelf tx ✅ -durable responses in challenging histologies ✅ Lots still to do for the field of CAR-NK www.thelancet.com/journals/lan...

Amazing and very important work for the field. 👏🏽👏🏽👏🏽

Every year this is how I feel after ASH. A final #ASHaiku Every year it comes ASH conference lights the path Purpose renewed #ASH24 #hematology #HemeSky #lymsm

Excited to be at ASH in my new role at SCRI! Stop by our booth to learn about exciting things happening in our network! #ASH24 #lymsm #CancerResearch

Want to hear about the targeting of BTK for the treatment of CLL and NHL? Then don't forget to watch our fantastic roundtable discussion with experts Tanya Siddiqi, Krish Patel & Alexey Danilov! Click here: 👉https://buff.ly/4f3mR7s👈 #iwNHL24 #LYMsm #CLLsm #NonHodgkinLymphoma

On the way to @ash-hematology.bsky.social 2024. Beautiful middle TN sunrise over Cumberland River. Excited for science, collaboration, and all the best of #hematology #hemesky #lymsm #lymsky #ASH2024

A very exciting time to join Sarah Cannon. Cutting edge research in rapidly growing programs.

Looking forward to full study presentation. I like the approach but devil is in the details. Followup is short and mPFS 16 mths R2 control arm not quite performing like AUGMENT (where R2 median pfs 27.6mths at 5yr f/u) but it is a randomized comparison. Are pts higher risk in this study 🤔? #lymsm

Glofi-PolaRCHP 95/97% pfs/os 👀🤯